Latest News
- June 24, 2025Two USFDA inspections in ophthalmology, with ZERO 483
- June 05, 2025Join CBCC at CPHI China 2025
- June 02, 2025Successfully completed a Phase 1a study for a US-based Innovator Biotech Company!
- May 26, 2025ANDA application for Paclitaxel Injection (Albumin bound) supported by CBCC has received Marketing Authorization from the USFDA
- May 20, 2025We’re Exhibiting at BIO 2025! Visit our booth #3480
June 24, 2025
Two USFDA inspections in ophthalmology, with ZERO 483
